B. Riley Wealth Advisors’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
B. Riley Wealth Advisors's DGX Position: Q4 2025 in Review
B. Riley Wealth Advisors sold out of Quest Diagnostics (DGX) in Q4 2025, closing a stake of 1,066 shares — an estimated $203K sold.
B. Riley Wealth Advisors first reported a position in DGX in Q2 2014 and held it in 18 quarters. The position peaked at $707K in Q3 2021. 1,049 funds tracked by Wall St. Rank hold DGX as of Q4 2025.
- B. Riley Wealth Advisors reported no remaining Quest Diagnostics position as of Q4 2025 after selling out during the quarter.
- B. Riley Wealth Advisors sold 1,066 Quest Diagnostics shares in Q4 2025, an estimated $203K.
- B. Riley Wealth Advisors first reported a position in Quest Diagnostics in Q2 2014 and held it in 18 quarters.
- B. Riley Wealth Advisors's Quest Diagnostics position peaked at $707K in Q3 2021.
- 1,049 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2025.
Based on B. Riley Wealth Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.